Citrate Anticoagulation in Dialysis for Liver and Kidney Failure
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at whether a blood thinner called citrate is safe and effective in patients who have both kidney and liver failure while on continuous dialysis in the ICU. It may help guide treatment for people with serious organ problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (ICU).
- You have acute kidney injury and need a special type of dialysis called continuous renal replacement therapy (CRRT).
- You have liver failure or significant liver problems (such as high liver enzymes or high bilirubin).
- You have shock that requires a strong blood pressure medicine (norepinephrine) or a second medicine for blood pressure.
- You are 18 years or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a customized approach to preventing blood clots during continuous kidney dialysis (CRRT) in patients whose bodies have trouble processing citrate, often due to liver problems or severe illness. The goal is to find the right citrate dose for each patient to keep the dialysis running safely.
This study looks at using a blood thinner called citrate during continuous kidney dialysis (renal replacement therapy) in critically ill patients with acute kidney injury. It aims to see if this approach is safe and workable for patients whose bodies may not process citrate normally.
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
This study compares two types of dialysis fluid (citrate-based vs acetate-based) to see which better helps protect blood pressure during intermittent dialysis. It may help people in intensive care who are at risk of dialysis-related low blood pressure.
This study tests how safe a specific blood thinner called “citrate” is when used during continuous kidney dialysis (CRRT) for people with AKI or kidney failure. If you qualify, your care team will compare citrate safety against standard approaches to see if it’s tolerable and safe.
This study tests whether a specific blood-thinning method using citrate works safely and effectively in critically ill patients whose kidneys have suddenly stopped working and need a special filtering machine. Researchers want to confirm that this approach prevents dangerous blood clots while keeping patients safe.
Hear when a new Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.